Limitations of this analysis include its retrospective nature; the inclusion of data from Caucasian patients only; the inclusion of data from only treatment naïve patients; the low number of cirrhotic patients; the use of the same score for patients with missing information on cirrhosis and those with no cirrhosis; and the absence of host IL28B genotype. The gene discussed is IFNL3; the disease is Cirrhosis.